TAS2R38 and colorectal carcinoma: Having the TAS2R38 AVI/AVI diplotype decreased the risk of CRC by approximately 25% compared to having the PAV haplotype [adjusted odds ratio (OR) = 0.74, 95% confidence interval (CI): 0.56–0.99].